Enabling Cell and Gene Therapy Start Ups to Thrive and Deliver

Director of Sales and Marketing Darrell Tanner reveals how MES and release by exception with POMSnet helps Cell and Gene Therapy company’s delivery right first time   We are seeing personalized medicine formally launch businesses into mainstream life sciences. Cell & Gene Therapy and CRISPR editing technology are integrating into the portfolio offering of many…

Details

Achieving MES Web-Based Architecture

Business Development Manager Roland Esquivel outlines one of our MES areas of expertise and how POMSnet software achieves web and cloud-based architecture For over 30 years now it seems Pharma, Biotech, and Medical Device have paid a heavy price for Manufacturing Execution System MES license and implementation without realizing much more benefit than basic compliance for electronic batch records. There are not many…

Details